Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Knut Pettersson"'
Autor:
Rob C. M. de Jong, Niek J. Pluijmert, Margreet R. de Vries, Knut Pettersson, Douwe E. Atsma, J. Wouter Jukema, Paul H. A. Quax
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract Annexin A5 (AnxA5) is known to have anti-inflammatory and anti-apoptotic properties. Inflammation and apoptosis are key processes in post-ischemic cardiac remodeling. In this study, we investigated the effect of AnxA5 on left ventricular (LV
Externí odkaz:
https://doaj.org/article/50bd8d889bfd42e0baca7bd420a4b082
Autor:
Jacinta M. Letters, Paul K. Witting, Julie K. Christison, Annika Weston Eriksson, Knut Pettersson, Roland Stocker
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 6, Pp 1104-1112 (1999)
Oxidation of lipoproteins is thought to be an early event in atherogenesis. To evaluate whether aortic lipoprotein lipid (per)oxidation contributes to atherosclerosis, we investigated the time-dependent changes to lipids and antioxidants in plasma an
Externí odkaz:
https://doaj.org/article/2c3326c9175645af9d044cbce1e71e99
Autor:
Fabiana Baganha, Thijs J. Sluiter, Rob C. M. de Jong, Louise A. van Alst, Hendrika A. B. Peters, J. Wouter Jukema, Mirela Delibegovic, Knut Pettersson, Paul H. A. Quax, Margreet R. de Vries
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 13662
International Journal of Molecular Sciences, 23(21). MDPI
International Journal of Molecular Sciences, 23(21). MDPI
Phosphorylcholine (PC) is one of the main oxLDL epitopes playing a central role in atherosclerosis, due to its atherogenic and proinflammatory effects. PC can be cleared by natural IgM antibodies and low levels of these antibodies have been associate
Autor:
Ewa Ninio, J.W. Jukema, Erna Peters, James R. Mitchell, S.A.P. Karabina, Johan Frostegård, R.C.M. Jong, A. Bergman, Margreet R. de Vries, I. Dahlbom, Michael R MacArthur, M.M. Ewing, M. Nordzell, D.J. Sexton, J.C. Karper, Paul H.A. Quax, Knut Pettersson, J. Kuiper
Publikováno v:
Journal of Internal Medicine, 290 (1)
Journal of Internal Medicine, 290(1), 141-156. WILEY
Journal of Internal Medicine
Journal of Internal Medicine, Wiley, 2020, ⟨10.1111/joim.13234⟩
Journal of Internal Medicine, 290(1), 141-156. WILEY
Journal of Internal Medicine
Journal of Internal Medicine, Wiley, 2020, ⟨10.1111/joim.13234⟩
Background Phosphorylcholine (PC) is an important pro‐inflammatory damage‐associated molecular pattern. Previous data have shown that natural IgM anti‐PC protects against cardiovascular disease. We aimed to develop a monoclonal PC IgG antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63977bd8d6d72a00632bfb05a3ee8956
https://hdl.handle.net/20.500.11850/465611
https://hdl.handle.net/20.500.11850/465611
Autor:
Douwe E. Atsma, J. Wouter Jukema, Rob C. M. de Jong, Margreet R. de Vries, Niek J. Pluijmert, Paul H.A. Quax, Knut Pettersson
Publikováno v:
Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine, 25(16), 7772-7782. WILEY
Journal of Cellular and Molecular Medicine, 25(16), 7772-7782. Wiley-Blackwell
Pluijmert, N J, de Jong, R C M, de Vries, M R, Pettersson, K, Atsma, D E, Jukema, J W & Quax, P H A 2021, ' Phosphorylcholine antibodies restrict infarct size and left ventricular remodelling by attenuating the unreperfused post-ischaemic inflammatory response ', Journal of Cellular and Molecular Medicine, vol. 25, no. 16, pp. 7772-7782 . https://doi.org/10.1111/jcmm.16662
Journal of Cellular and Molecular Medicine, 25(16), 7772-7782. WILEY
Journal of Cellular and Molecular Medicine, 25(16), 7772-7782. Wiley-Blackwell
Pluijmert, N J, de Jong, R C M, de Vries, M R, Pettersson, K, Atsma, D E, Jukema, J W & Quax, P H A 2021, ' Phosphorylcholine antibodies restrict infarct size and left ventricular remodelling by attenuating the unreperfused post-ischaemic inflammatory response ', Journal of Cellular and Molecular Medicine, vol. 25, no. 16, pp. 7772-7782 . https://doi.org/10.1111/jcmm.16662
Phosphorylcholine is a pro‐inflammatory epitope exposed on apoptotic cells, and phosphorylcholine monoclonal immunoglobulin (Ig)G antibodies (PC‐mAb) have anti‐inflammatory properties. In this study, we hypothesize that PC‐mAb treatment reduc
Autor:
Mia, Ståhle, Johanna M U, Silvola, Sanna, Hellberg, Margreet, de Vries, Paul H A, Quax, Jeffrey, Kroon, Petteri, Rinne, Alwin, de Jong, Heidi, Liljenbäck, Nina, Savisto, Anna, Wickman, Erik S G, Stroes, Seppo, Ylä-Herttuala, Pekka, Saukko, Tommy, Abrahamsson, Knut, Pettersson, Juhani, Knuuti, Anne, Roivainen, Antti, Saraste
Publikováno v:
JACC: Basic to Translational Science
Visual Abstract
Highlights • Phosphorylcholine is a pro-inflammatory epitope in atherogenic oxidized phospholipids. • This study investigated effects of a novel monoclonal IgG1 antibody against PC on vascular function and atherosclerotic inf
Highlights • Phosphorylcholine is a pro-inflammatory epitope in atherogenic oxidized phospholipids. • This study investigated effects of a novel monoclonal IgG1 antibody against PC on vascular function and atherosclerotic inf
Autor:
Niek J. Pluijmert, Margreet R. de Vries, J. Wouter Jukema, Paul H.A. Quax, Knut Pettersson, Rob C. M. de Jong, Douwe E. Atsma
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports
Scientific Reports, 8(1), 6753
Scientific Reports, 8
Scientific Reports
Scientific Reports, 8(1), 6753
Scientific Reports, 8
Annexin A5 (AnxA5) is known to have anti-inflammatory and anti-apoptotic properties. Inflammation and apoptosis are key processes in post-ischemic cardiac remodeling. In this study, we investigated the effect of AnxA5 on left ventricular (LV) functio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a196889bcab7b287d9798e796fc81b
https://doi.org/10.1038/s41598-018-25143-y
https://doi.org/10.1038/s41598-018-25143-y
Publikováno v:
AIO research meeting
Publikováno v:
International Vascular Biology Meeting
Frontiers in Cardiovascular
Frontiers in Cardiovascular
Autor:
Rcm De Jong, M.R. de Vries, Johan Wouter Jukema, Pha Quax, Niek J. Pluijmert, Knut Pettersson
Publikováno v:
Cardiovascular Research. 114:S125-S126